ArticleBioinformation2026
Diagnostic efficacy of pulse oximetry versus Ankle-Brachial index for peripheral vascular disease in type 2 diabetes.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Peripheral Vascular Disease (PVD) is a debilitating macrovascular complication associated with Type 2 Diabetes Mellitus (T2DM) with significant mortality. This remains undiagnosed in the asymptomatic cases due to diabetic neuropathy. Therefore, it is of interest to evaluate the diagnostic accuracy of the pulse oximetry against the gold-standard Ankle-Brachial Index (ABI). Data shows a high prevalence of PVD with ABI, whereas the pulse oximetry validated moderate sensitivity but low specificity, limiting its utility as a standalone diagnostic tool. While ABI remains the superior standard for definitive diagnosis, pulse oximetry offers a viable, cost-effective preliminary screening option for high-risk populations in resource-constrained healthcare centers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.